Andere talen Torii Pharmaceutical Co., Ltd.

Aandelen

4551

JP3635800000

Beurs gesloten - Japan Exchange Andere beurzen 08:00:00 08-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
3.975 ^JPY	-0,25%		+0,76%	+11,81%

13/02	LIM Advisors trekt aandeelhoudersvoorstel gedeeltelijk in	CI
09/02	Torii Pharmaceuticals verzet zich tegen aandeelhoudersvoorstel	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

LIM Advisors Partially Withdraws Shareholder Proposal	13/02
Torii Pharmaceuticals Opposes Shareholder Proposal	09/02
Torii Pharmaceutical - Top-line Results of Phase 3 Clinical Study of TO-208 for the Treatment of Molluscum Contagiosum in Japan	18/12
Verrica Pharmaceuticals Development and Commercialization Partner, Torii Pharmaceutical Co., Ltd., Announces Positive Top-line Results from a Confirmatory Phase 3 Trial of TO-208	18/12
Verrica Pharmaceuticals' Partner Reports Positive Data From Phase 3 Trial of Skin Infection Treatment	15/12
Torii Pharmaceutical : Top-line Results of Phase 3 Clinical Study of TO-208 for the Treatment of Molluscum Contagiosum in Japan	15/12
Torii Pharmaceutical Co., Ltd. Announces Positive Top-Line Results from a Confirmatory Phase 3 Trial of TO-208 for the Treatment of Molluscum Contagiosum in Japan	15/12
Torii Pharmaceutical : Signing of an Agreement for the Exclusive Development and Commercialization of GRAZAX®,an Allergen Immunotherapy (Sublingual Immunotherapy) Drug for Grass Pollinosis in Japan	13/12
ALK Abello Adds Grass Pollen Allergy Drug to Torii License Deal in Japan	12/12
ALK-Abelló A/S Expands Partnership with Torii Pharmaceutical Co., Ltd. in Japan	12/12
BioCryst Amends Deal With Torii Pharmaceutical for Orladeyo's Commercialization in Japan; Shares Rise	30/11
Torii Pharmaceutical : Financial Results for the First Nine Months of Fiscal Year Ending December 2023	31-10-23
Torii Pharmaceutical - JT Files New Drug Application of JTE-061 Cream, Aryl hydrocarbon Receptor agonist, for the Treatment of Atopic Dermatitis and Plaque Psoriasis in Japan	18-09-23
Torii Pharmaceutical : JT Files New Drug Application of JTE-061 Cream,Aryl hydrocarbon Receptor (AhR) agonist,for the Treatment of Atopic Dermatitis and Plaque Psoriasis in Japan	15-09-23
Torii Pharmaceutical : Financial Results for the First Three Months of Fiscal Year Ending December 2023	28-04-23
Torii Pharmaceutical Announces Voting Results	30-03-23
Torii Pharmaceutical : Views on Report from ISS, a Proxy Advisory Firm, On Proposals for ’s General Meeting of Shareholders	16-03-23
Torii Pharmaceutical : Notice of the Opinion of the Board of Directors Regarding the Shareholder Proposal	17-02-23
Torii has announced Medium-Term Management Plan 2023-2025	13-02-23
Torii Pharmaceutical : has announced Medium-Term Management Plan 2023-2025	10-02-23

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Torii Pharmaceutical Co., Ltd.

Aandelen

4551

JP3635800000

Andere talen

Filters